…to provide more clarity around what constitutes compliance and better support to assist with compliance,” Kris Haltmeyer, vice president of policy analysis for the Blue Cross Blue Shield Association, told…
Expert Commentary
…HIV medicine is called antiretroviral therapy, or ART, and is prescribed as a single pill or combination of medications from several drug classes. HIV medicine reduces the amount of HIV…
Expert Commentary
…that examines absenteeism among U.S. public school students or a clinical trial of a new drug designed to treat Alzheimer’s disease. When researchers design a study, they start by defining…
Expert Commentary
…disciplinary hearing or investigation, according to a review of state policies published in 2021 in the Criminal Justice Policy Review. “Supermax housing illustrates a policy that was implemented with little…
Expert Commentary
…drug-related offenses, the effect could be driven by racial bias in media messaging,” Ash and Poyker write. “Alternatively, it could be that ‘tough-on-drugs’ rather than ‘tough-on-crime’ rhetoric matters in this…
Expert Commentary
…and Christopher Laingen. farmdocDaily, March 2022. Precision Conservation: Linking Set-Aside and Working Lands Policy Scott Swinton. Applied Economic Perspectives and Policy, February 2022. Farm Bill Primer: Conservation Title Congressional Research…
Expert Commentary
…Health Insurance Coverage? Nirmita Panchal; et al. Kaiser Family Foundation, March 2022 Quick summary: The report, by the nonprofit policy organization Kaiser Family Foundation, explores how the use of mental…
Expert Commentary
…without even a moment’s hesitation, get approved for a $50,000 Alzheimer’s drug that probably won’t make a difference in their quality of life or wellbeing, but it’s impossible to get…
Expert Commentary
…Annenberg Public Policy Center of the University of Pennsylvania finds that knowledge about mpox has declined, following an increase between July and August 2022, and so has the fear of…
Expert Commentary
…under-representation of older adults in clinical trials through a policy lens, reporting on the severity of the problem through a review of past research and outlining potential policy solutions. Older…
Expert Commentary